| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-05 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |